Skip to main content
. Author manuscript; available in PMC: 2016 Jul 15.
Published in final edited form as: Clin Cancer Res. 2015 Mar 31;21(14):3274–3285. doi: 10.1158/1078-0432.CCR-14-3118

Figure 2.

Figure 2

oHSV treatment increases macrophage [CD11b+CD45hi] activation. A–C. Left- Representative scatter plots of CD86+ [A], LY6C+ [B], and MHCII+ [C] macrophages in the tumor and non-tumor bearing hemispheres following oHSV [rQNestin34.5] or PBS treatment [n=5/group]. Right- Quantification of the percentage and cell numbers of macrophages [CD11b+CD45hi] expressing the indicated marker following oHSV or PBS treatment in the tumor and non-tumor bearing hemisphere [n=5/group]. Quantified data is mean values ± SD.

HHS Vulnerability Disclosure